Dublin, Ireland-based Medtronic recently filed for FDA approval on its new artificial pancreas device and expects to introduce the product to the market in 2017, according to Bloomberg.
Supply Chain
The Food and Drug Administration on Tuesday approved Gilead Sciences' combination drug as the first available treatment for all six forms of hepatitis C.
The current healthcare environment is dynamic and challenging. Hospital System leadership needs to develop a strategy to improve care while reducing costs.
Orig3n, a Boston-based biotech company, is partnering with the San Francisco 49ers to reward football fans who support the company's human genome research.
Pfizer plans to build a $350 million biotech center in China in an effort to get its drugs to the Asian market faster, according to Reuters.
Advertisement
Roche's new multiple sclerosis drug earned priority review status from the Food and Drug Administration, potentially moving up the drug's launch date, according to Reuters.
Novartis will collaborate with Monrovia, Calif.-based Xencor to develop bispecific antibodies to treat cancer, according to Reuters.
The Food and Drug Administration placed a clinical hold on Regulus Therapeutics' investigational drug to treat chronic hepatitis C virus infection, according to Reuters.
A bipartisan alliance of former Food and Drug Administration commissioners want the agency to become an independent federal body, according to Fortune.
The U.S. Supreme court rejected on Monday San Diego-based Sequenom's petition to review litigation that invalidated its patent on a new type of prenatal test, according to Reuters.